Baca berita tanpa iklan. Gabung
February 17, 2021, 05.25 PM

JAKARTA, – Indonesia’s state-owned pharmaceutical company Bio Farma will produce more Covid-19 vaccine after receiving the bulk vaccine from China’s Sinovac shortly.

“We have made an agreement with Sinovac who will send 140 million doses of Covid-19 bulk vaccine based on the agreed timeline,” said Bio Farma president director Honesti Basyir in a press conference on Tuesday, February 16.

Also readBPOM Greenlights Sinovac Covid-19 Vaccine Manufactured by Bio Farma

This announcement was made following the production of 13 million doses of ready-to-use vaccine by Bio Farma. Previously, the company received 15 million doses of bulk vaccine from Sinovac on January 12.

"This achievement will certainly be an encouragement for us to maintain the stability of the supply of the covid-19 vaccine," said Honesti.

Also readIndonesian Traditional Market Traders to Get Covid-19 Vaccine in Stages

He further added with the issuance of the Emergency Use Authorization (EUA) for the Covid-19 vaccine, Bio Farma would distribute 7.5 million doses of ready-to-use vaccine for the second phase of the mass vaccination program.

“The 7.5 million doses will be provided for non-healthcare workers,” he said.

(Writer: Haryanti Puspa Sari | Editor: Diamanty Meiliana)



Dapatkan update berita pilihan dan breaking news setiap hari dari Mari bergabung di Grup Telegram " News Update", caranya klik link, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.

Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

April 14, 2023, 12.38 PM

Indonesia Detects New Covid Arcturus Variant

Baca berita tanpa iklan. Gabung
Baca berita tanpa iklan. Gabung


Baca berita tanpa iklan. Gabung
Baca berita tanpa iklan. Gabung
Close Ads